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Elevated reactive oxygen species (ROS) are linked to
insulin resistance and islet dysfunction. Manganese
superoxide dismutase (SOD2) is a primary defense
against mitochondrial oxidative stress. To test the hypoth-
esis that heterozygous SOD2 deletion impairs glucose-
stimulated insulin secretion (GSIS) and insulin action,
wild-type (sod2+/+) and heterozygous knockout mice
(sod2+/2) were fed a chow or high-fat (HF) diet, which
accelerates ROS production. Hyperglycemic (HG) and
hyperinsulinemic-euglycemic (HI) clamps were per-
formed to assess GSIS and insulin action in vivo. GSIS
during HG clamps was equal in chow-fed sod2+/2 and
sod2+/+ but was markedly decreased in HF-fed sod2+/2.
Remarkably, this impairment was not paralleled by re-
duced HG glucose infusion rate (GIR). Decreased GSIS
in HF-fed sod2+/2 was associated with increased ROS,
such as superoxide ion. Surprisingly, insulin action deter-
mined by HI clamps did not differ between sod2+/2 and
sod2+/+ of either diet. Since insulin action was unaffected,
we hypothesized that the unchanged HG GIR in HF-fed
sod2+/2 was due to increased glucose effectiveness. In-
creased GLUT-1, hexokinase II, and phospho-AMPK pro-
tein in muscle of HF-fed sod2+/2 support this hypothesis.
We conclude that heterozygous SOD2 deletion in mice,
a model that mimics SOD2 changes observed in diabetic
humans, impairs GSIS in HF-fed mice without affecting
insulin action.
Elevated reactive oxygen species (ROS) are linked to insulin
resistance and islet dysfunction of type 2 diabetes (1–3).
Overstimulation of b-cells by nutrients results in increased
mitochondrial ROS formation (4), which could directly
cause macromolecular (e.g., lipid, DNA) damage or indi-
rectly result in oxidative stress by activating stress-sensitive
pathways such as nuclear factor-kB (NFkB), p38 mitogen-
activated protein kinase (MAPK), Jun NH2-terminal kinase
(JNK)/stress-activated protein kinase, and hexosamine (3).
Activation of these pathways has been shown to lead to
signiﬁcant deterioration of glucose-stimulated insulin secre-
tion (GSIS) and other indices of b-cell function (5,6). Even
though there is strong evidence that ROS are critical in
causing b-cell dysfunction, effective therapeutic strategies
including antioxidant therapies that prevent or delay this
damage are limited. One reason for this is the lack of
knowledge of the speciﬁc species of ROS that are respon-
sible for the process.
Superoxide ion (O2_ ˉ ) is produced by various cellular
oxidase reactions and is a natural byproduct of the mito-
chondrial electron transport system (7,8). The mitochon-
drial isoform of the superoxide dismutase, manganese
superoxide dismutase (SOD2), catalyzes the conversion
of O2_ ˉ to hydrogen peroxide (H2O2). H2O2 may then be
broken down to H2O and O2 by antioxidant enzymes,
such as glutathione peroxidases, peroxiredoxins, and cat-
alase. Although H2O2 has been shown to be involved in
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sensing signals that disrupt b-cell function (9), the role of
O2_ ˉ and SOD2 in b-cell dysfunction is unknown.
The role of SOD2 in the regulation of muscle insulin
sensitivity also remains a point of contention. Both mito-
chondrial O2_ ˉ and H2O2 serve as metabolic sensors func-
tionally linking the mitochondrial redox state of a cell to
insulin sensitivity (1,2). There is some debate as to whether
increased SOD2 expression has beneﬁcial or deleterious
effects on muscle insulin sensitivity since SOD2 decreases
O2_ ˉ but increases H2O2. Reduced O2_ ˉ has been shown to
improve insulin action in muscle (1), and elevated H2O2 links
excess fat intake to insulin resistance (2).
Mice with a heterozygous knockout of SOD2 (sod2+/2),
a model that mimics SOD2 changes observed in diabetic
humans (10), were used to study the role of this key mi-
tochondrial O2_ ˉ scavenging enzyme in insulin secretion
and insulin sensitivity. Complete SOD2 knockout in mice
is lethal (11,12). In the current study, the hypothesis that
sod2+/2 mice have impaired GSIS and insulin action was
tested in vivo. For this purpose validated hyperglycemic
(HG) and hyperinsulinemic-euglycemic (HI) clamps coupled
with isotopic tracer techniques were used to assess insulin
secretion and action in conscious, unrestrained stress-free
mice.
RESEARCH DESIGN AND METHODS
Mouse Models
Wild-type (sod2+/+) and sod2+/2 C57BL/6J mice were
fed chow (LabDiet 5001; www.labdiet.com/Products/
StandardDiets/index.html) or a high-fat (HF) diet (F3282,
Bio-Serv; www.bio-serv.com/product/HFPellets.html) for 16
weeks. The calorie breakdown was 29% protein, 13% fat, and
58% carbohydrate for the chow diet and 15% protein, 59%
fat, and 26% carbohydrate for the HF diet. Noticeably, the
HF diet is also a low-protein, low-carbohydrate diet com-
pared with the chow diet. Body composition was determined
by nuclear magnetic resonance. Vanderbilt and East Carolina
Animal Care and Use Committees approved all animal
procedures.
In Vivo HG and HI Clamp
Protocol
Mice had catheters implanted in the left carotid artery
and the right jugular vein for blood sampling and
intravenous infusion, respectively, 5 days prior to the
study (13,14). HG and HI clamps were performed on 5-h
fasted mice (13). The clamp procedure used in these stud-
ies is unique in that it has been validated from a number
of standpoints, including stability of blood glucose over
time, absence of stress, insulin measurements, and ab-
sence of a hematocrit fall (13). For HG clamps, arterial
glucose was clamped at 250 mg/dL using a variable glu-
cose infusion rate (GIR). GIR is an index of glucose toler-
ance during the HG clamp. Plasma insulin and C-peptide
were determined during clamps. For HI clamps [3-3H]glucose
was primed (2.4 mCi) and continuously infused (basal
0.04 mCi/min; clamp 0.12 mCi/min) into the jugular
vein catheter. At time 0, infusion of insulin (4 mU/kg/min)
was started and continued for 155 min. Blood was sampled
at 80–120 min for the determination of plasma [3-3H]glucose
speciﬁc activity. HI clamp insulin was measured at t = 100
and 120 min. At 120 min, 2[14C]deoxyglucose (13 mCi)
was administered intravenously. Blood samples were
taken thereafter for plasma 2[14C]deoxyglucose measure-
ments. After the last sample, mice were anesthetized and
tissues were excised and freeze clamped.
Plasma and Tissue Sample Processing
Plasma insulin and C-peptide were determined by ELISA
or radioimmunoassay (Millipore). Glycogen was measured
in gastrocnemius and liver extracts (15). 3H and 14C ra-
dioactivity was determined by liquid scintillation counting
(16). Glucose appearance (Ra) and disappearance (Rd)
rates were calculated using non-steady-state equations
(17). Endogenous (primarily hepatic) glucose appearance
(endoRa) was determined by subtracting the GIR from
total Ra. The glucose metabolic index (Rg) was calculated
as previously described (18).
Ex Vivo Islet Perifusion and Static Incubation
Islet Isolation, Function Assay, and Islet Area
Measurement
We detected no sex effects in vivo, thus islets were
isolated only from male mice for the ex vivo measure-
ments. Mouse islets were isolated as described (19) and
cultured in RPMI 1640 containing 10% FBS and 5 mmol/L
glucose at 37°C overnight. GSIS was assessed by perifusion
and static culture using size-matched islets and normalized
to islet equivalents. Two secretagogues, glucose (16.7 mmol/L)
and 3-isobutyl-1-methylxanthine (IBMX; 100 mmol/L)
were used during perifusion. For static GSIS, islets were
cultured in 3 mmol/L glucose for 2 h and then 20 mmol/L
glucose for an additional 2 h. Insulin in the culture
medium was determined by ELISA. Islet size was assessed
with MetaMorph version 7.7 (Universal Imaging) on 324–
926 islets/genotype (20).
Quantitative RT-PCR
RNA was extracted from isolated islets (Ambion). RNA
integrity number was .8. Quantitative PCR was per-
formed using TaqMan primers/probes (Applied Bio-
systems). Data were normalized to 18s, and relative
changes in mRNA expression were calculated by the com-
parative DCt method (19,20). Minimum Information for
Publication of Quantitative Real-Time PCR Experiments
guidelines was followed for quantitative RT-PCR experi-
ments (21).
Western Blotting
SOD2 expression in muscle was measured in mitochon-
dria isolated from gastrocnemius (Imgenex). SOD2 ex-
pression in islets was measured in isolated islet extracts.
Akt, GLUT-1, hexokinase II, and AMPK were measured in
gastrocnemius homogenate as described previously (22).
The antibodies used were SOD2 antibody (Assay Designs),
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phospho-Akt (Ser473) and Akt, hexokinase II, phospho-
AMPK (Thr172) and AMPK-a antibodies (Cell Signaling),
and GLUT-1 antibody (Abcam).
SOD2 Activity Assay
SOD2 activity was measured in gastrocnemius mitochon-
dria using the Superoxide Dismutase Assay Kit (Cayman).
In Situ Measurement of Superoxide
Pancreata were ﬁxed in 4% paraformaldehyde and frozen
in optimal cutting temperature compound (VWR Scien-
tiﬁc Products). Cryosections (5 mm) were washed by PBS
followed by dihydroethidium (DHE) staining for 30 min
(23). After washing with PBS, slides were mounted and
imaged. Fluorescence was quantiﬁed using ImageJ.
Measurements of Thiobarbituric Acid-Reactive
Substances and Protein Carbonyl Groups
Thiobarbituric acid-reactive substances (TBARS) and pro-
tein carbonyl groups were measured in islet extracts
and gastrocnemius homogenates using the TBARS and
the Protein Carbonyl Colometric Assay Kit, respectively
(Cayman).
Reduced and Oxidized Glutathione Measurements
Reduced glutathione (GSH) and oxidized glutathione
(GSSG) were measured in gastrocnemius homogenates
using the BIOXYTECH GSH/GSSG-412 assay kit (Oxis
Research). For GSSG measurement, 5 mmol/L 1-methyl-
2-vinylpyridinium triﬂuoromethanesulfonate was added
to scavenge all reduced thiols.
Mitochondrial H2O2 Level
Mitochondrial H2O2 level was measured by continuous
spectroﬂuorometric monitoring oxidation of Amplex
Red in permeabilized muscle ﬁbers (2). This is a measure-
ment of the balance of H2O2 between its production and
breakdown. Exogenous Cu/Zn-SOD (SOD1) (for the de-
tection of nonmatrix sources of superoxide production)
was not included in the assay to isolate the effects of
SOD2 deﬁciency.
Statistical Analysis
Data are expressed as mean 6 SEM. Statistical analyses
were performed using either Student t test or two-way
ANOVA followed by Tukey post hoc tests as appropriate.
The signiﬁcance level was at P , 0.05.
RESULTS
Basal Characteristics of the sod2+/2 Mice
Chow-fed sod2+/+ and sod2+/2 mice had comparable body
weight, percent body fat, and basal 5-h fasting arterial
glucose and insulin (Table 1). HF feeding increased body
weight, percent body fat, and arterial glucose and insulin
equally in both genotypes. Arterial nonesteriﬁed fatty acid
was not affected by genotype or diet (Table 1).
Deletion of one SOD2 allele resulted in a 50% re-
duction in SOD2 protein in the islets (Fig. 1A) and a 60%
reduction in muscle mitochondria (Fig. 1B). HF feeding
had no effects on SOD2 protein in islets or muscle (Fig.
1A and B). Consistent with protein measurements, SOD2
activity in muscle mitochondria was decreased by 60% in
sod2+/2 mice relative to sod2+/+ mice (Fig. 1C).
In Vivo Insulin Secretion (HG Clamp)
HG and HI clamps were performed in both male and
female mice. No sex effect was detected. Therefore, data
from both sexes were combined. Arterial glucose was 250
mg/dL during the clamp (Fig. 2A). GIR was slightly higher
in the chow-fed mice compared with the HF-fed mice, but
genotype had no effect on GIR (Fig. 2B). In the chow-fed
mice, arterial insulin and C-peptide was comparable be-
tween genotypes (Fig. 2C and D). However, both insulin
and C-peptide were markedly decreased in the HF-fed
sod2+/2 compared with HF-fed sod2+/+, reﬂecting a marked
reduction in insulin secretion (Fig. 2E and F).
Ex Vivo Insulin Secretion (Isolated Islets)
The in vivo ﬁndings in GSIS were recapitulated in isolated
islets ex vivo. Islets isolated from chow-fed sod2+/+ and
sod2+/2 mice had identical insulin peaks in response to
glucose and IBMX (Fig. 3A). Insulin peak response to
glucose in the HF-fed sod2+/2 mice was smaller compared
with that in the HF-fed sod2+/+ mice during the islet peri-
fusion (Fig. 3B). The quantiﬁcation of the area under the
peak showed a 30% reduction in sod2+/2 mice (Fig. 3C).
Impaired insulin secretion in HF-fed sod2+/2 mice was
speciﬁc to glucose stimulation, as IBMX-stimulated insu-
lin secretion was identical in HF-fed sod2+/+ and sod2+/2
(Fig. 3D). To conﬁrm the differences seen with islet peri-
fusion, insulin secretion during static incubation of islets
with glucose was assessed. Since differences in GSIS were
only observed in the HF-fed mice, static incubation of
Table 1—Basal (5-h fasted) characteristics of sod2+/2 mice
Chow HF
sod2+/+ sod2+/2 sod2+/+ sod2+/2
Body weight (g) 25 6 1 24 6 1 34 6 1† 35 6 1†
Fat mass (%) 9 6 1 8 6 0.4 30 6 1† 28 6 2†
Arterial glucose (mg$dL21) 123 6 3 131 6 4 152 6 6† 155 6 6†
Insulin (ng$mL21) 0.7 6 0.1 0.9 6 0.2 2.0 6 0.2† 2.4 6 0.3†
Nonesteriﬁed fatty acid (mmol/L) 0.72 6 0.04 0.75 6 0.07 0.75 6 0.06 0.67 6 0.03
All data are expressed as mean 6 SEM. n = 9–11. †P , 0.05 compared with chow with the same genotype.
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islets was performed in the HF-fed mice. Insulin did not
differ between HF-fed sod2+/+ and sod2+/2 mice at 3
mmol/L glucose, but was decreased in the islets of HF-
fed sod2+/2 mice at 20 mmol/L glucose compared with
sod2+/+ mice (Fig. 3E).
Reduction in GSIS in isolated islets of HF-fed sod2+/2
mice was associated with increased ROS levels determined
by the ROS indicator dichloroﬂuorescein diacetate (Fig.
4A). Protein carbonyl groups and TBARS were also higher
in the islets from HF-fed sod2+/2 mice (Fig. 4B and C).
Superoxide concentration determined by DHE staining
was increased by HF feeding and heterozygous deletion
of SOD2 independently (Fig. 4D). The reduction in GSIS
was not associated with changes in gene expression of
proteins involved in the insulin secretory pathways (Fig.
4E). Furthermore, impaired GSIS in the HF-fed sod2+/2
mice was not associated with changes in islet size and
areas (Fig. 4F).
In Vivo Insulin Action (HI Clamp)
Since the HG GIR was the same between HF-fed sod2+/+
and sod2+/2 mice despite the marked reduction in arterial
insulin in the sod2+/2 mice, we tested whether insulin ac-
tion might be increased in these mice. The HI clamp was
used to assess insulin action in vivo. Arterial glucose was
150 mg/dL during the HI clamp in all groups (Fig. 5A).
Infusion of insulin increased arterial insulin to a similar
extent in all mice (Chow sod2+/+ 2.4 6 0.3 ng/mL; chow
sod2+/2 3.0 6 0.5 ng/mL; HF sod2+/+ 3.0 6 0.2 ng/mL; HF
sod2+/2 3.1 6 0.1 ng/mL). GIR was lower in HF-fed mice
relative to chow-fed mice as expected, but genotype did not
affect GIR (Fig. 5B). EndoRa was not different between
groups in the basal or insulin-clamped state (Fig. 5C). Basal
Rd was not different between groups (Fig. 5D). Rd during
the HI clamp in sod2+/+ and sod2+/2 mice was not different
on a chow diet and was decreased to a similar extent by HF
feeding (Fig. 5D). Rg in gastrocnemius, superﬁcial vastus
lateralis, and heart was similar between genotypes on both
chow and HF diets (Fig. 5E). Diaphragm Rg was slightly
decreased in chow-fed sod2+/2 mice compared with chow-
fed sod2+/+ mice but was the same between genotypes on
HF diet (Fig. 5E). Changes in muscle insulin signaling after
the HI clamp were consistent with metabolic ﬂux measure-
ments observed during the HI clamp. Phosphorylated Akt
(p-Akt), total Akt, and p-Akt/Akt ratio were decreased by
HF feeding (Fig. 5F). Consistent with similar muscle Rg,
p-Akt, total Akt, and p-Akt/Akt ratio did not differ between
sod2+/+ and sod2+/2 mice, independent of diet (Fig. 5F).
These results show that a 50% SOD2 reduction does not
inﬂuence insulin action. Since HG GIR was the same in HF-
fed sod2+/+ and sod2+/2 mice even though arterial insulin
was reduced in sod2+/2 mice and insulin action was not
increased, one can deduce that heterozygous SOD2 deletion
increases glucose effectiveness, the ability of glucose to
facilitate its own disposal (24).
Glucose Effectiveness During the HG Clamp
Expression of GLUT-1, hexokinase II, and AMPK and
activation of AMPK (p-AMPK/AMPK ratio), which are
associated with glucose effectiveness, were increased in
the HF-fed sod2+/2 mice as compared with sod2+/+ mice in
muscle excised after the HG clamp (Fig. 6A–C). Muscle
Figure 1—SOD2 expression and activity in islets and muscle. A: Western blotting of SOD2 in isolated islets. GAPDH was used as a loading
control. B: Western blotting of SOD2 in muscle mitochondria. V-DAC was used as a loading control. Representative bands were displayed.
Data are normalized to chow-fed sod2+/+ mice and represented as mean 6 SEM. C: SOD2 activity was measured in mitochondria isolated
from gastrocnemius muscle. n = 7–8. *P < 0.05 compared with sod2+/+ within a diet.
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glycogen was not different between the HF-fed sod2+/+
and sod2+/2 mice (Fig. 6D), but liver glycogen was higher
in the HF-fed sod2+/2 mice (Fig. 6E). The latter ﬁnding is
again consistent with an increase in glucose effectiveness.
Muscle Redox State
GSH/GSSG was decreased in muscle of sod2+/+ mice by HF
feeding (Fig. 7A), suggesting a shift to a more oxidized
redox environment. sod2+/2 signiﬁcantly decreased mus-
cle GSH/GSSG in chow-fed mice and caused no further
decrease in HF-fed mice (Fig. 7A). Protein carbonyl groups
were not different between chow-fed sod2+/2 and sod2+/+
mice but tended to be increased in HF-fed sod2+/2 mice
(P = 0.07) (Fig. 7B). Muscle TBARS were not affected by
genotype or diet (Fig. 7C).
Muscle mitochondrial H2O2 level was measured during
both succinate- and palmitoylcarnitine-supported state-4
respiration. Succinate increased H2O2 level in a dose-
dependent manner (Fig. 7D). HF feeding caused an eleva-
tion in H2O2 level in the muscle of sod2
+/+ mice (Fig. 7D and
E). sod2+/2, however, had no effect on either succinate- or
palmitoylcarnitine-supported H2O2 level in mice on either
diet (Fig. 7D and E).
DISCUSSION
SOD2 is a primary defense against oxidative stress, since
ROS are largely generated on the matrix side of the inner
mitochondrial membrane (25). In the current study, we
used a mouse model with genetically reduced SOD2 levels,
so as to increase mitochondrial O2_ ˉ. The putative role of
SOD2 or mitochondrial O2_ ˉ in regulation of GSIS and
insulin action was tested using glucose clamp techniques
that are unique in that they do not require restraint,
severing of the tail, or mouse handling. Our results dem-
onstrate for the ﬁrst time that sod2+/2 causes dramatic
impairments in GSIS in mice fed HF but not in lean mice.
The observation of reduced GSIS in HF-fed sod2+/2 mice
in vivo is also evident in isolated islets. Decreased GSIS is
likely attributable to increased O2_ ˉ in islets of knockout
mice. We conclude that SOD2 reduction impairs GSIS
when mitochondrial ROS is further elevated by HF diet
and that this combination exceeds the adaptive capacity
of the b-cells. Surprisingly, sod2+/2 does not affect insulin
action. The ability of insulin to suppress hepatic glucose
production and to stimulate glucose utilization is not sen-
sitive to the changes in SOD2 in the current study.
Pancreatic b-cells are particularly vulnerable to oxida-
tive stress due to low antioxidant enzyme expression (26).
It is suggested that an imbalance between excess ROS
production and limited antioxidant enzymes damages se-
cretory capacity and viability of b-cells (26,27). Our
results showing that a 50% reduction in islet SOD2 dra-
matically decreases GSIS both in vivo and in isolated islets
Figure 2—In vivo GSIS as assessed by the HG clamp. (A) Arterial glucose, (B) GIR, (C and E) arterial insulin, and (D and F ) arterial C-peptide
were measured throughout the HG clamp. Data are represented as mean 6 SEM. n = 13 for chow-fed sod2+/+ (7 females/6 males); n = 11
for chow-fed sod2+/2 (5 females/6 males); n = 12 for HF-fed sod2+/+ (5 females/7 males); n = 13 for HF-fed sod2+/2 (6 females/7 males).
*P < 0.05 compared with sod2+/+.
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of the HF-fed mice are consistent with these previous
studies, suggesting that SOD2, the primary mitochondrial
O2_ ˉ scavenger, is critical in regulating the redox state and
therefore the secretory capacity of b-cells. Decreased GSIS
in HF-fed sod2+/2 mice is associated with increased O2_ ˉ.
One could conclude that SOD2 reduction increases mito-
chondrial O2_ ˉ, which contributes to elevated ROS and
impaired GSIS. However, SOD2 converts O2_ ˉ to H2O2.
A reduction in SOD2 could potentially decrease mitochon-
drial and cytosolic H2O2 in islets. Although H2O2 has been
shown to be involved in sensing signals disrupting b-cell
functions (9,28), it has also been shown that H2O2 de-
rived from glucose metabolism serves as an important
metabolic signaling molecule for insulin secretion (29).
Therefore, the contribution of potential changes in
H2O2 on impaired GSIS in HF-fed sod2
+/2 mice cannot
be ruled out. In the presence of HF feeding, both excessive
O2_ ˉ and H2O2 could negatively impact GSIS. Therefore
one might predict that a combination of SOD2 and cata-
lase, which converts H2O2 to O2 and H2O, would have the
most antioxidative effect.
Mitochondrial dysfunction and oxidative stress
have been implicated in the metabolic deterioration of
b-cells, yet the mechanisms are not fully understood. It
has been shown that transient exposure of b-cells to 200
mmol/L H2O2 decreases the secretory response to
glucose, accompanied by reduced oxygen consumption,
glucose-induced ATP generation, subunits of the respi-
ratory chain, and expression of genes responsible for
mitochondrial biogenesis (30). These ﬁndings suggest
that mitochondrial dysfunction is potentially contribut-
ing to the impaired GSIS resulted from oxidative stress.
Mitochondrial dysfunction is normally associated with
increased ROS formation (31). While elevated ROS di-
rectly damage and oxidize DNA, protein, and lipids, ROS
can also activate a number of stress-sensitive pathways
that have been linked to decreased insulin secretion (3).
These include activation of several key inﬂammatory
pathways such as NFkB, p38 MAPK, JNK, and Janus
kinase/STAT pathways and islet-enriched transcription
factors (28). Activation of the NFkB and JNK/STAT
pathways has been associated with ROS-mediated pan-
creatic b-cell death and therefore decreased GSIS (32).
In addition to apoptosis, ROS has also been shown to
decrease insulin gene expression by downregulating the
expression of transcription factor Pdx-1 (26,28). How-
ever, here we show that the HF-fed sod2+/2 mice had nor-
mal expression of genes that encode proteins involved in
the regulation of insulin secretion. In addition, islet size is
expanded equally in HF-fed sod2+/2 and sod2+/+ mice.
These results suggest that the decreased islet secretory
capacity of the SOD2 knockout mice is due to a defect in
Figure 3—Ex vivo GSIS as assessed by islet perifusion and static incubation. A and B: Isolated islets were perifused with 16.7 mmol/L
glucose and 16.7 mmol/L glucose plus IBMX. C and D: Areas under the insulin peaks in response to glucose and IBMX stimulation were
quantiﬁed. E: Isolated islets were cultured and incubated with either 3 or 20 mmol/L glucose, and insulin was measured in the culture
medium. Data are represented as mean 6 SEM. n = 4–8 males for all groups. *P < 0.05 compared with sod2+/+ with the same diet/
treatment. IEQs, islet equivalents.
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the regulation of insulin secretion (e.g., glucose sensing,
insulin exocytosis) rather than insulin biosynthesis or
b-cell mass.
Heterozygous SOD2 deletion had no effects on insulin
action either in healthy lean mice or HF diet–induced
obese mice. This was despite a decrease in muscle GSH/
GSSG, an indication of overall cellular redox state, in
chow-fed sod2+/2 mice. Hoehn et al. (1) reported that
sod2+/2 mice had impaired glucose tolerance on a chow
diet. Our results show that these effects on glucose toler-
ance are not due to changes in insulin action. The inter-
pretation of glucose tolerance testing is complicated, as
glycemic excursions can be due to a number of factors
(33), including insulin secretion, insulin clearance, and
glucose effectiveness (34). Although we did not see a de-
fect in insulin secretion in the chow-fed sod2+/2 mice at
Figure 4—Redox status, gene expression, and areas of islets. A: ROS production was assessed by the ROS indicator dichloroﬂuorescein
diacetate in islets isolated from the HF-fed mice. B and C: Protein carbonyl groups and TBARS were measured in isolated islet extracts. D:
Superoxide level was measured by DHE staining in frozen pancreatic sections. Representative images are displayed and ﬂuorescence was
quantiﬁed in 10–30 islets per genotype for chow-fed mice and 60–70 islets per genotype for HF-fed mice. E: mRNA levels were determined
by quantitative real-time PCR and normalized to HF-fed sod2+/+ mice. F: Islet size was quantiﬁed and representative images are displayed.
Data are represented as mean 6 SEM. n = 4–8 males for all groups. *P < 0.05 compared with sod2+/+ with the same diet; #P < 0.05
compared with chow-fed mice with the same genotype. IEQs, islet equivalents; Ins, insulin.
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an arterial glucose of 250 mg/dL, a higher arterial glucose
concentration may have provoked insulin secretory
defects, thereby contributing to the impaired glucose tol-
erance. Nevertheless, our results are consistent with the
data of Hoehn et al. (1) that showed that overexpression
of SOD2 in L6 cells had no effect on insulin action and
provide evidence that SOD2 reduction is not a critical
determinant of muscle insulin action.
The effect of H2O2 on muscle glucose uptake is contro-
versial. H2O2 has been reported to induce an insulin signaling
defect in skeletal muscle cells (35). This defect is associ-
ated with a selective loss of insulin receptor substrate-1
and insulin receptor substrate-2 proteins, in part related
to a p38 MAPK–dependent mechanism (36). Chronic ele-
vation of mitochondrial H2O2 has been shown to link
excess fat intake to insulin resistance in both rodents
and humans (2). On the other hand, low levels of H2O2
are shown to be required for normal cellular function
and intracellular signaling (8). In the current study, we
found that mitochondrial H2O2 level, however, was not
altered by the reduction of SOD2 in the muscle. These
results are consistent with previous studies that showed
that muscle mitochondrial H2O2 level was not affected by
SOD2 overexpression (37), suggesting that even a 50–60%
decrease in SOD2 expression in muscle mitochondria is not
rate limiting for converting O2_ ˉ to H2O2. Although the
enzymatic activity of SOD1, the cytosolic isoform of SOD
and glutathione peroxidase, remains unchanged in the
chow-fed sod2+/2 mice (11), compensations from other an-
tioxidant mechanisms, especially during HF feeding, are
possible.
Consistent with the H2O2 data, further measurements
of the muscle redox state showed that GSH/GSSG, pro-
tein carbonyl groups, and TBARS levels were not different
Figure 5—In vivo insulin action as determined by the HI clamp. (A) Arterial glucose, (B) GIR, (C ) endoRa, (D) Rd, and (E ) Rg, an index of
muscle glucose uptake, were determined during the HI clamp. F: Western blotting of p-Akt and total Akt in gastrocnemius muscle post the
HI clamp. Representative bands are displayed. GAPDH was used as a loading control. The integrated intensities of bands are normalized to
chow-fed sod2+/+ and represented as mean 6 SEM. n = 9 for chow-fed sod2+/+ (4 females/5 males); n = 10 for chow-fed sod2+/2
(5 females/5 males); n = 12 for HF-fed sod2+/+ (5 females/7 males); n = 13 for HF-fed sod2+/2 (6 females/7 males). f, P < 0.05 for the
main diet effect; +P < 0.05 compared with basal with the same genotype; #P < 0.05 compared with chow-fed mice with the same
genotype; *P < 0.05 compared with sod2+/+ with the same diet. SVL, superﬁcial vastus lateralis.
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between muscles of HF-fed sod2+/2 and sod2+/+ mice.
These results further suggest that muscle is resistant to
the changes in redox state caused by a 60% reduction of
SOD2. The unchanged redox state in the muscle may
explain the lack of changes in insulin sensitivity in the
HF-fed sod2+/2 mice. In contrast, pancreatic b-cells are
particularly vulnerable to such a reduction, possibly due
to low antioxidant enzyme expression (26). Total ROS,
O2_ ˉ, protein carbonyl groups, and TBARS were increased
in the islets of HF-fed sod2+/2 mice. These differences in
the oxidative damage status between muscle and islets
provide mechanistic insight for the observed phenotype
differences between tissues.
Surprisingly, muscle protein carbonyl groups level was
found to be decreased in the HF-fed sod2+/+ mice compared
with chow-fed sod2+/+ mice. Despite high uncertainty,
one possible postulation is that the HF diet contains lower
protein and carbohydrate content compared with the chow
diet. These differences in protein and carbohydrate content
between diets may create unforeseen effects on redox sta-
tus of protein in muscle. Moreover, these differences in
diets may also have direct impacts on insulin secretion
and action. Fortunately, the concluding results of the cur-
rent study emphasizes a genetic effect rather than a diet
effect. Therefore metabolic effects caused by the differ-
ences in nutritional proﬁle of diets shall remain the same
between genotypes.
Hyperglycemia per se exerts direct effects on glucose
homeostasis, independent of changes in insulin or other
hormonal signals (38). This phenomenon is referred to as
“glucose effectiveness.” The loss of glucose effectiveness in
type 2 diabetes contributes importantly to hyperglycemia
(24). Interestingly, HF-fed sod2+/2 mice exhibited increased
glucose effectiveness during hyperglycemia. This was related
to increased GLUT-1, hexokinase II expression, and activa-
tion and expression of AMPK. These proteins involved in
Figure 6—Glucose effectiveness during the HG clamp. (A) Western blotting of GLUT-1, (B) hexokinase II, and (C) phosphorylation of AMPK
and total AMPK was performed in gastrocnemius muscle extracts post HG clamp. GAPDH was used as loading control. Representative
bands are displayed. The integrated intensities of bands are normalized to chow-fed sod2+/+ and are represented as mean 6 SEM. n = 4–5
(males). D and E: Muscle and liver glycogen content was determined in tissues post HG clamp. n = 6–7 (males). *P < 0.05 compared with
sod2+/+ HF. HK II, hexokinase II.
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glucose utilization may serve to compensate for the defects
in insulin secretion.
While this article was in preparation, Muscogiuri et al.
(39) reported that mice with SOD1 deletion have glucose
intolerance secondary to impairments in b-cell function
rather than defects on insulin sensitivity. These results are
consistent with our ﬁndings and, when combined with the
current study, highlight a critical role of SOD enzymes in
regulating insulin secretion. However, there exist important
differences in the role for SOD1 and SOD2 in insulin secre-
tion. Our study speciﬁcally targeted SOD2 with its mitochon-
drial ROS scavenging capacity, while the study of Muscogiuri
et al. (39) targeted the cytosolic compartment of the cell
where SOD1 resides. Our results show that the level of
SOD2 and mitochondrial O2_ ˉ/H2O2 are more critical in the
impairment of insulin secretion seen with heterozygous de-
letion of SOD2 (with 50% remaining protein and activity of
SOD2). Furthermore, the activity of SOD1 and other an-
tioxidant enzymes regulate the transcription of key
b-cell genes such as Pdx1, insulin, GLUT-2, and glucoki-
nase (40–42). However, our results show that mitochon-
drial SOD2 does not affect the mRNA of these genes.
These results indicate that SOD1 and SOD2 impact in-
sulin secretion by distinctive mechanisms.
In conclusion, these data demonstrate that SOD2 re-
duction dramatically decreases pancreatic b-cell secretory
capacity under dietary model of insulin resistance without
affecting insulin action. These studies show for the ﬁrst time
that pancreatic islets are particularly sensitive to a 50% re-
duction of SOD2, yet skeletal muscle is not. Our mouse
model of heterozygous SOD2 knockout mimics changes ob-
served in diabetic humans (10,43,44) and thus is relevant to
human disease. Our results suggest that efforts to target
mitochondrial antioxidant enzymes may be beneﬁcial in
b-cell dysfunction and insulin resistance. Identiﬁcation of
tissue-speciﬁc therapeutic targets is particularly important
because of the different sensitivity of tissues to changes in
redox state.
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